ABCG4 and non-small cell lung carcinoma: To investigate the relationship between ABCG4 expression and the clinical outcome of NSCLC patients treated with cisplatin-based combination chemotherapy, univariate and multivariate analyses were performed using the Cox proportional hazards model to determine whether the prognostic value of ABCG4 was independent from other factors.